Point: The rationale for universal lipid screening and treatment in children

Journal of Clinical Lipidology
Irwin Benuck

Abstract

Screening a healthy population for future harmful diseases has the potential of reducing the risk of later morbidity and mortality with early identification and intervention. However, it is important that the screening meets acceptable standards, and the benefits of the screening outweigh risks. The recently published "Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents" (National Heart Lung Blood Institute Guidelines) carefully examined the multiple risk factors for coronary artery disease that begins in childhood but may not become problematic until years later. The evidence-based guidelines give many recommendations that are focused on identification, prevention, and intervention. Included in the guidelines are useful suggestions for improving lifestyle and food choices. In the section on lipids and lipoprotein, careful consideration was given to universal screening of children between 9 and 11 years of age with no known cardiac risk factors and again, if needed, between 17 and 21 years of age. Children with cardiac risk factors may be screened earlier. The section continues with rationale for medical management of children who are refractory to other interventions. ...Continue Reading

References

Mar 15, 1992·The American Journal of Cardiology·I BenuckH S Traisman
Nov 1, 1991·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·E CohenG L Yates
Dec 19, 1990·JAMA : the Journal of the American Medical Association·R M Lauer, W R Clarke
Mar 1, 1995·Archives of Pediatrics & Adolescent Medicine·I BenuckM Donovan
Nov 5, 1999·JAMA : the Journal of the American Medical Association·T N Robinson
Jun 1, 2002·Archives of Pediatrics & Adolescent Medicine·John R KnightGrace Chang
Dec 31, 2002·Journal of the American College of Cardiology·Saskia de JonghJohn J P Kastelein
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Shengxu LiGerald S Berenson
Mar 11, 2004·JAMA : the Journal of the American Medical Association·Ali H MokdadJulie L Gerberding
Jul 5, 2006·Pediatrics·Ardis L OlsonJames Hurley
Oct 4, 2006·Pediatrics·C Alex McMahanUNKNOWN Pathobiological Determinants of Atherosclerosis in Youth Research Group
Jul 4, 2008·Pediatrics·Stephen R DanielsUNKNOWN Committee on Nutrition
Aug 14, 2008·The Journal of Clinical Endocrinology and Metabolism·Peter O Kwiterovich
Jan 15, 2010·JAMA : the Journal of the American Medical Association·Cynthia L OgdenKatherine M Flegal
Apr 20, 2012·Drugs·Marjet J A M BraamskampAlbert Wiegman
Apr 3, 2013·Pediatrics·Joshua D Uy, Atu Agawu
Apr 3, 2013·Pediatrics·Thomas B NewmanStephen B Hulley
Apr 3, 2013·Pediatrics·Irwin Benuck, Patrick E McBride
Apr 3, 2013·Pediatrics·Brian W McCrindleRae-Ellen W Kavey
Sep 10, 2014·JAMA : the Journal of the American Medical Association·D Meeike KustersBarbara A Hutten

❮ Previous
Next ❯

Citations

Dec 23, 2016·Clinical Pediatrics·Carole StipelmanNicole L Mihalopoulos
Oct 13, 2017·Annals of Pediatric Endocrinology & Metabolism·Dong-Yoon YooEun-Gyong Yoo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.